Tumor Suppressor Genes

Tuberous sclerosis is caused by loss-of-function mutations in TSC1 or TSC2 tumor suppressor genes

Tumor Suppressor Genes (TSGs)

Read this in Cancer Pharmacology: Cell Cycle, Oncogenes & Drug Targets

What our notes say

Study material on Tumor Suppressor Genes

Practice questions on Tumor Suppressor Genes

Why must BOTH copies of a tumor suppressor gene be lost for tumor development, unlike oncogenes which require mutation of only one allele?

Answer: B. This follows Knudson's two-hit hypothesis. One functional copy of a tumor suppressor gene is sufficient for normal function, so both must be lost. Oncogenes are gain-of-function mutations where one mutant copy is sufficient. ---

In the adenoma-carcinoma sequence of colon cancer, what is the significance of loss of the tumor suppressor gene on chromosome 18q?

Answer: B. The multistep progression typically follows: APC loss → KRAS activation → 18q loss → TP53 loss. The 18q loss occurs in intermediate stages of progression. ---

Which tumor suppressor gene can trigger apoptosis in response to DNA damage?

Answer: C. p53 is activated by DNA damage and can induce cell cycle arrest for repair or trigger apoptosis if damage is irreparable. It acts as the "guardian of the genome" and induces pro-apoptotic proteins like Bax. --- ---

Which tumor suppressor gene can trigger apoptosis in response to DNA damage?

Answer: C. p53 is activated by DNA damage and can induce cell cycle arrest for repair or trigger apoptosis if damage is irreparable. It acts as the "guardian of the genome" and induces pro-apoptotic proteins like Bax. --- ---

Which tumor suppressor gene can trigger apoptosis in response to DNA damage?

Answer: C. p53 is activated by DNA damage and can induce cell cycle arrest for repair or trigger apoptosis if damage is irreparable. It acts as the "guardian of the genome" and induces pro-apoptotic proteins like Bax. --- ---

What protein does the NF2 tumor suppressor gene produce?

Answer: A. The NF2 tumor suppressor gene produces neurofibromin-2 (merlin), which facilitates E-cadherin-mediated contact inhibition. ---

Related topics